438 related articles for article (PubMed ID: 30619092)
1. The Role of RNA Editing in Cancer Development and Metabolic Disorders.
Kung CP; Maggi LB; Weber JD
Front Endocrinol (Lausanne); 2018; 9():762. PubMed ID: 30619092
[TBL] [Abstract][Full Text] [Related]
2. RNA editing of BFP, a point mutant of GFP, using artificial APOBEC1 deaminase to restore the genetic code.
Bhakta S; Sakari M; Tsukahara T
Sci Rep; 2020 Oct; 10(1):17304. PubMed ID: 33057101
[TBL] [Abstract][Full Text] [Related]
3. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
Smith HC
RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
[TBL] [Abstract][Full Text] [Related]
4. Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.
Severi F; Conticello SG
RNA Biol; 2015; 12(4):389-97. PubMed ID: 25806564
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.
Rosenberg BR; Hamilton CE; Mwangi MM; Dewell S; Papavasiliou FN
Nat Struct Mol Biol; 2011 Feb; 18(2):230-6. PubMed ID: 21258325
[TBL] [Abstract][Full Text] [Related]
6. APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.
Soleymanjahi S; Blanc V; Davidson N
RNA; 2021 Jun; 27(8):876-90. PubMed ID: 34083494
[TBL] [Abstract][Full Text] [Related]
7. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
[TBL] [Abstract][Full Text] [Related]
8. RNA rewriting, recoding, and rewiring in human disease.
Zipeto MA; Jiang Q; Melese E; Jamieson CH
Trends Mol Med; 2015 Sep; 21(9):549-59. PubMed ID: 26259769
[TBL] [Abstract][Full Text] [Related]
9. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-to-inosine RNA editing and human disease.
Slotkin W; Nishikura K
Genome Med; 2013; 5(11):105. PubMed ID: 24289319
[TBL] [Abstract][Full Text] [Related]
11. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
Karagianni K; Pettas S; Christoforidou G; Kanata E; Bekas N; Xanthopoulos K; Dafou D; Sklaviadis T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327657
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.
Teng BB; Ochsner S; Zhang Q; Soman KV; Lau PP; Chan L
J Lipid Res; 1999 Apr; 40(4):623-35. PubMed ID: 10191286
[TBL] [Abstract][Full Text] [Related]
14. ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer.
Roberts JT; Patterson DG; King VM; Amin SV; Polska CJ; Houserova D; Crucello A; Barnhill EC; Miller MM; Sherman TD; Borchert GM
Processes (Basel); 2018 May; 6(5):. PubMed ID: 30197877
[TBL] [Abstract][Full Text] [Related]
15. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
Cho CJ; Myung SJ; Chang S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
[TBL] [Abstract][Full Text] [Related]
16. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
[TBL] [Abstract][Full Text] [Related]
17. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
[TBL] [Abstract][Full Text] [Related]
18. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
19. RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE).
Dafou D; Kanata E; Pettas S; Bekas N; Dimitriadis A; Kempapidou G; Lagoudaki R; Theotokis P; Touloumi O; Delivanoglou N; Kesidou E; Xanthopoulos K; Grigoriadis N; Papavasiliou FN; Sklaviadis T
Cells; 2022 Nov; 11(22):. PubMed ID: 36429012
[TBL] [Abstract][Full Text] [Related]
20. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
